Science · Open for opinions
Will the FDA grant Breakthrough Therapy designation to LSD for the treatment of anxiety by October 31, 2026?
Considers decisions between 09/17 and 10/31, motivated by the prediction that LSD treatments for anxiety could be approved by 2027. 37 opinions, 70% No
- Yes — 30%
- No — 70%
Deadline: October 31, 2026 at 11:59 PM UTC · 37 opinions
Resolution rules
Considers decisions between 09/17 and 10/31, motivated by the prediction that LSD treatments for anxiety could be approved by 2027.
Source: www.newscientist.com
Frequently asked questions about this event
How is this event resolved?
Janela de apuração: de 17/09/2026 (00:00, horário de Brasília) até 31/10/2026 (23:59). Fatos, anúncios ou eventos anteriores ao início da janela não contam. Resolve como 'Sim' se a FDA conceder formalmente o status de 'Breakthrough Therapy' ao LSD para o tratamento da ansiedade. A confirmação deve ocorrer por meio de comunicados no site da Food and Drug Administration (fda.gov) ou na sua base de registros. Caso contrário, resolve como 'Não'.
How are points scored?
Points depend on the share of votes your side had when you gave your opinion. Being right earns 100 minus that share. Being wrong costs that share.
Right now No has 70% of the votes: an opinion on it that turns out right earns about 30 points, a wrong one costs about 70.